Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 119 results for "claris lifesciences"

Claris Lifesciences gets reaffirmation of credit ratings

This page uses frames, but your browser doesn't Capital Market, 1 week ago

4 images for claris lifesciences

India Infoline, 4 weeks ago
Business Standard India, 4 weeks ago
India Infoline, 1 month ago
Business Standard India, 1 month ago

Global Anesthesia & Respiratory Devices Market Worth USD 24.2 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Ambu, Baxter, Carefusion - Research and Markets

Research and Markets has announced the addition of the "Anesthesia and Respiratory Devices: Global Markets" report to their offering. Research and Markets has announced the addition of the "Anesthesia and Respiratory Devices: Global Markets" ...
 Minyanville3 days ago Research and Markets - Global Anesthesia & Respiratory Devices Market Value of USD 24.2 Billion by 2020 - Trends, Technologies & Opportunities Report 2016-2020 - Key Vendors: Pall, Penlon, Teleflex  PR Newswire3 days ago BioSimilar Market (Global & USA) 2021 - E.U. is the Major Industry with 19 Approved Biosimilars in Use  TickerTech.com1 week ago Global Intravenous Solutions Market to Grow at a CAGR of 5.79% During the Period 2016 - 2020; Finds New Report  Digital Journal2 weeks ago
[x]  

IV fluid makers threaten to steer clear of Kerala after price cap

Thiruvananthapuram: Kerala may be heading for a shortage of intravenous fluids in a few months as dealers threaten to stop distribution of the essential medical care item that has been brought under the price control mechanism in the state. The ...
 Manorama Online1 week ago
United News of India

Claris gets Establishment Inspection Report from USFDA

Sterile injectables company Claris Lifesciences Ltd, on Monday, said it has received the Establishment Inspection Report (EIR) for its manufacturing facility located near Ahmedabad, from the USF...
 Business Line4 weeks ago Claris, Granules units get US FDA approval  Moneycontrol.com4 weeks ago Claris announces receipt of EIR from the US FDA  United News of India4 weeks ago Claris Lifesciences hits 20% upper circuit  India Infoline4 weeks ago
[x]  
India Infoline

Claris Lifesciences slumps 4% on decline in net profit

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline1 month ago Claris Lifesciences consolidated net declines by 66% in Q4  PharmaBiz1 month ago Claris Lifesciences dips on disappointing Q4 results  Smart Investor1 month ago Claris Lifesciences slumps 5%  India Infoline1 month ago
[x]  

Claris Lifesciences trades jubilantly on getting EIR from USFDA for Ahmedabad's manufacturing facility

SENSEX 26694.15 31.45 0.12% NIFTY 8167.15 11.35 0.14% Industry: Medical/Healthcare Company Claris Lifesciences Ltd Claris Lifesciences is currently trading at Rs. 215.55, up by 13.65 points or 6.76% from its previous closing ...
 Finalaya.com3 weeks ago Claris Lifesciences extends rally on USFDA EIR for Gujarat facility  Economic Times3 weeks ago Claris Lifesciences gains on USFDA EIR for Gujarat facility  Religare Securities3 weeks ago Claris Lifesciences gets EIR from USFDA for Ahmedabad's facility  Religare Securities4 weeks ago
Livemint.com

BRIEF: Claris shares gain 20% on completing successful audit by USFDA [Mint, New Delhi]

May 30--HYDERABAD -- Claris Lifesciences Ltd shares rose 20% to Rs.201.90 on the BSE on Monday after the company said the US drug regulator found its facility near Ahmedabad "acceptable" after an establishment inspection report (EIR). The ...
 Bloomberg4 weeks ago Claris shares gain 20% on completing successful audit by USFDA  Livemint.com4 weeks ago

Claris Lifesciences stock zooms 20%

Shares of Claris Lifesciences today soared 20 per cent after the company received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Ahmedabad. The stock jumped 20 per cent to settle at Rs 201.90 ...
 Business Standard4 weeks ago
Business Standard India

Claris Lifesciences soars 20% as manufacturing facility receives EIR from USFDA

Related to : Claris Lifesciences Ltd Claris Lifesciences Ltd BSE 30 May 16 | 02:05 PM 201.90 33.65 (20%) NSE 01 Jan 70 | 05:30 AM 0.00 0 (0%) Claris Lifesciences is locked in upper circuit of 20% at Rs 202 on the BSE after the ...
 Smart Investor4 weeks ago

Claris Lifesciences slumps 7% as drugmaker reports 60% fall in Q4 net

NEW DELHI: Shares of Claris Lifesciences, an intravenous fluids and injectable drugs maker, slumped nearly 7 per cent in trade on after the company posted a 60 per cent YoY decline in its consolidated net profit to Rs 4 crore in the March quarter, ...
 Economic Times1 month ago Claris Lifesciences slumps as drugmaker reports 60% fall in Q4 net  Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less